EVP, Chief Scientific Officer · Sana Biotechnology, Inc. · Common Stock
Tax withholding — administrative, little informational value
$169K reported value · 28.9% of prior position
Disclosed 0 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Patel Dhavalkumar DhirajlalEVP, Chief Scientific Officer |  SANASana Biotechnology, Inc.Option exercise | M | — 125.0K sh | Aug 27, 2026 traded Aug 26, 2026 | |
| 21 | Patel Dhavalkumar DhirajlalEVP, Chief Scientific Officer | SANASana Biotechnology, Inc. Option exercise | M | — 125.0K sh | Aug 27, 2026 traded Aug 26, 2026 | |
| 9 | Seitz MichelleDirector | SANASana Biotechnology, Inc. Grant or award | A | — 90.0K sh | Jun 5, 2026 traded Jun 4, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $169,159
Patel Dhavalkumar Dhirajlal filed this Form 4 reporting a tax withholding of SANA on Aug 27, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.